374 related articles for article (PubMed ID: 17187388)
1. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.
Bérard A; Ramos E; Rey E; Blais L; St-André M; Oraichi D
Birth Defects Res B Dev Reprod Toxicol; 2007 Feb; 80(1):18-27. PubMed ID: 17187388
[TBL] [Abstract][Full Text] [Related]
2. SSRI antidepressants and birth defects.
Prescrire Int; 2006 Dec; 15(86):222-3. PubMed ID: 17167929
[TBL] [Abstract][Full Text] [Related]
3. Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.
Bar-Oz B; Einarson T; Einarson A; Boskovic R; O'Brien L; Malm H; Bérard A; Koren G
Clin Ther; 2007 May; 29(5):918-926. PubMed ID: 17697910
[TBL] [Abstract][Full Text] [Related]
4. The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis.
Bérard A; Iessa N; Chaabane S; Muanda FT; Boukhris T; Zhao JP
Br J Clin Pharmacol; 2016 Apr; 81(4):589-604. PubMed ID: 26613360
[TBL] [Abstract][Full Text] [Related]
5. Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.
Diav-Citrin O; Shechtman S; Weinbaum D; Wajnberg R; Avgil M; Di Gianantonio E; Clementi M; Weber-Schoendorfer C; Schaefer C; Ornoy A
Br J Clin Pharmacol; 2008 Nov; 66(5):695-705. PubMed ID: 18754846
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant use in pregnancy and the risk of cardiac defects.
Huybrechts KF; Palmsten K; Avorn J; Cohen LS; Holmes LB; Franklin JM; Mogun H; Levin R; Kowal M; Setoguchi S; Hernández-Díaz S
N Engl J Med; 2014 Jun; 370(25):2397-407. PubMed ID: 24941178
[TBL] [Abstract][Full Text] [Related]
8. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.
Gentile S; Bellantuono C
J Clin Psychiatry; 2009 Mar; 70(3):414-22. PubMed ID: 19254517
[TBL] [Abstract][Full Text] [Related]
9. Paroxetine use during pregnancy and perinatal outcomes including types of cardiac malformations in Quebec and France: a short communication.
Bérard A; Sheehy O; Damase-Michel C; Crespin S
Curr Drug Saf; 2012 Jul; 7(3):207-10. PubMed ID: 22950376
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
Bérard A; Zhao JP; Sheehy O
BMJ Open; 2017 Jan; 7(1):e013372. PubMed ID: 28082367
[TBL] [Abstract][Full Text] [Related]
11. First-trimester use of paroxetine and congenital heart defects: a population-based case-control study.
Bakker MK; Kerstjens-Frederikse WS; Buys CH; de Walle HE; de Jong-van den Berg LT
Birth Defects Res A Clin Mol Teratol; 2010 Feb; 88(2):94-100. PubMed ID: 19937603
[TBL] [Abstract][Full Text] [Related]
12. Sertraline use during pregnancy and the risk of major malformations.
Bérard A; Zhao JP; Sheehy O
Am J Obstet Gynecol; 2015 Jun; 212(6):795.e1-795.e12. PubMed ID: 25637841
[TBL] [Abstract][Full Text] [Related]
13. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births.
Gao SY; Wu QJ; Sun C; Zhang TN; Shen ZQ; Liu CX; Gong TT; Xu X; Ji C; Huang DH; Chang Q; Zhao YH
BMC Med; 2018 Nov; 16(1):205. PubMed ID: 30415641
[TBL] [Abstract][Full Text] [Related]
14. Duration of antidepressant use during pregnancy and risk of major congenital malformations.
Ramos E; St-André M; Rey E; Oraichi D; Bérard A
Br J Psychiatry; 2008 May; 192(5):344-50. PubMed ID: 18450657
[TBL] [Abstract][Full Text] [Related]
15. Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity-score matched cohort in CPRD.
Margulis AV; Abou-Ali A; Strazzeri MM; Ding Y; Kuyateh F; Frimpong EY; Levenson MS; Hammad TA
Pharmacoepidemiol Drug Saf; 2013 Sep; 22(9):942-51. PubMed ID: 23733623
[TBL] [Abstract][Full Text] [Related]
16. Paroxetine in the first trimester and the prevalence of congenital malformations.
Cole JA; Ephross SA; Cosmatos IS; Walker AM
Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1075-85. PubMed ID: 17729379
[TBL] [Abstract][Full Text] [Related]
17. Paroxetine use in pregnancy and increased risk of heart defects: Evaluating the evidence.
Einarson A
Can Fam Physician; 2010 Aug; 56(8):767-8. PubMed ID: 20705881
[TBL] [Abstract][Full Text] [Related]
18. Does paroxetine cause cardiac malformations?
O'Brien L; Einarson TR; Sarkar M; Einarson A; Koren G
J Obstet Gynaecol Can; 2008 Aug; 30(8):696-701. PubMed ID: 18786292
[TBL] [Abstract][Full Text] [Related]
19. Paroxetine may increase risk for congenital malformations.
Cuzzell JZ
Dermatol Nurs; 2006 Feb; 18(1):68. PubMed ID: 16617525
[No Abstract] [Full Text] [Related]
20. Paroxetine exposure during pregnancy and cardiac malformations.
Scialli AR
Birth Defects Res A Clin Mol Teratol; 2010 Mar; 88(3):175-7. PubMed ID: 20175190
[No Abstract] [Full Text] [Related]
[Next] [New Search]
